Website News and Research

RSS

Healthscreen Solutions announces fiscal year end 2009 financial results

Healthscreen Solutions Inc., Canada's premier provider of physician practice enhancement services and electronic medical record (EMR) software, today announced its record fiscal year end 2009 financial results.

28 Jan 2010

Kensey Nash announces financial results for second quarter of fiscal year 2010

Kensey Nash Corporation, a leading medical technology company that provides innovative solutions and technologies for a wide range of medical procedures, today reported the results for its three and six months ended December 31, 2009.

28 Jan 2010

Interdisciplinary team evaluates the economic impact of mental illness in Spain

An interdisciplinary team coordinated by researchers from the University of Castilla La Mancha (UCLM) and the Canary Islands Health Service has evaluated the economic impact of mental illness in Spain, and estimated their social cost. According to the study, despite health resources being invested to alleviate the effects of such illnesses, informal care and lost work time places a heavy burden on society.

28 Jan 2010

Tyco International reports $0.63 in diluted EPS from continuing operations for fiscal first-quarter of 2010

Tyco International Ltd. today reported $0.63 in diluted earnings per share (EPS) from continuing operations for the fiscal first quarter of 2010 and diluted EPS from continuing operations before special items of $0.65 per share.

28 Jan 2010

JST chooses Scopus Custom Data to conduct citation linkage analysis

Elsevier announced today that Scopus Custom Data, the underlying source of Scopus.com, the world's largest abstract and citation database, was chosen by Japan Science and Technology (JST) to conduct citation linkage analysis between scientific articles and patents.

28 Jan 2010

Phthalate exposure can affect child's neurobehavioral development, says study

A new study led by Mount Sinai researchers in collaboration with scientists from Cornell University and the U.S. Centers for Disease Control and Prevention, has found higher prenatal exposure to phthalates-manmade chemicals that interfere with hormonal messaging-to be connected with disruptive and problem behaviors in children between the ages of 4 and 9 years.

28 Jan 2010

FreeRxReminder.com launches new online Institutional Reminder Service

Patient compliance with their drug regimen is of vital importance to both the individual and the various parties that are involved in the patient's health, like doctors, pharmacies and insurance companies.

28 Jan 2010

January is ‘Thyroid Awareness Month’

We often go to great lengths to look and feel our best. Yet many never realize that one of the keys to a healthy body and a productive life rests just below the neck.

27 Jan 2010

WellWorld Science officially launches Livea in the U.S.

After more than 30 years of research and an extensive open-label weight loss study, WellWorld Science® announces the official U.S. launch of Livea®, a doctor-developed, non-prescription, patent-pending appetite-control supplement that is unlike any other dietary supplement on the market.

27 Jan 2010

Health News Digest features Sunridge International's patented 'PNT' procedure

Sunridge International's patented "PNT" procedure was the topic of discussion in one of Health News Digest's recent articles published on January 24, 2010.

27 Jan 2010

Kelyniam Global receives prototype order to make Custom Cranial Implants

Kelyniam Global, Inc. announces today that the company has received a prototype order from a California distributor to make Custom Cranial Implants.

27 Jan 2010

DuPont announces fourth quarter 2009 earnings

DuPont's fourth-quarter 2009 earnings were $.48 per share, compared to a fourth-quarter 2008 loss of $.70 per share. Excluding significant items, fourth-quarter 2009 earnings were $.44 per share versus a $.28 per share loss in the prior year (see Schedule B.).

27 Jan 2010

Update on Cardium Therapeutics' plans for commercial development of Generx

Cardium Therapeutics reported today that its Cardium Biologics division provided an update on plans for the continuing commercial development of Generx™ (alferminogene tadenovec, Ad5FGF-4), a DNA-based angiogenic therapy product candidate for patients with coronary artery disease.

27 Jan 2010

AIM releases new educational podcasts on its patient safety website section

American Imaging Management, Inc. (AIM), a leading diagnostic imaging benefit management and technology company with health plan clients representing more than 35 million consumers and an operating subsidiary of WellPoint, Inc. ( WLP), announced the release of new educational podcasts on the company's patient safety section of its Web site at www.americanimaging.net/safety.

27 Jan 2010

European study results on consumer use of nutrition information on food labels available online

Results from a European study on consumer use of nutrition information on food labels and their understanding of front-of-pack nutrition information, are now available ahead of print on the website of the Journal of Public Health.

25 Jan 2010

Canadian conference on managing legal & business risks in clinical trials

The nature of clinical trials is constantly changing in the ever-more globalized and adapting market. In this increasingly-scrutinized industry, it is important to maintain a transparent process, to appropriately manage risks and to avoid abuses, in order to get a piece of this multi-billion dollar industry. How? By effectively managing the legal and business risks!

23 Jan 2010

Challenges related to premarket clearance process for medical devices: FDA schedules public meeting

The U.S. Food and Drug Administration announced today that it has scheduled a public meeting on Feb. 18, 2010, to discuss key challenges related to the premarket notification, or 510(k) process, used to review and clear certain medical devices marketed in the United States. The FDA receives more than 3,000 510(k) submissions each year.

23 Jan 2010

Vaccination for children: Pros and cons

ProCon.org, a nonpartisan 501(c)3 nonprofit public charity dedicated to promoting critical thinking, created the new website http://vaccines.procon.org to explore the core question "Should any vaccines be required for children?"

23 Jan 2010

Osteotech adopts Stockholder Rights Plan to discourage unfair takeover tactics

Osteotech, Inc., a leader in the emerging field of biologic products for regenerative healing, announced today that its Board of Directors adopted a Stockholder Rights Plan. The rights plan is designed to discourage coercive or unfair takeover tactics and to provide fair and equal treatment for all stockholders of the Company in the event that an unsolicited offer is made to acquire the Company.

23 Jan 2010

NEB's Double Digest Finder and Enzyme Finder tools now available for iPhone and iPod Touch

New England Biolabs' (NEB) popular web tools, Double Digest Finder and Enzyme Finder, are now available for the iPhone™ and iPod® Touch. These tools to help design restriction enzyme experiments are frequently visited on the NEB website, www.neb.com; making them available as free downloads brings their accessibility closer to the bench.

From New England Biolabs 23 Jan 2010